Document Detail
Research Title: Sailor Study
Sponsor: Genentech, Inc.
Investigators: Mathew W. MacCumber, M.D., Principal Investigator; Jack A. Cohen, M.D., Kirk H. Packo, M.D., Pauline T. Merrill, M.D.
Description: Patients will initially receive one injection of 0.5mg of Ranibizumab (Lucentis) after which the doctor will decide whether further doses of 0.5mg are warranted (patients may receive a total of 12 injections [one per month] during the course of the study)
Recruitment: Closed to Follow Up
Project Personnel: Sarah L.
Location(s): Illinois Retina Associates, S.C./Rush University Medical Center, 1725 West Harrison Street, Chicago, IL 60612
|